Over the last few years, scientists and entrepreneurs have flocked to developing medicines that target RNA, the genetic ...

For leaders in business, failing to learn the lessons of a crisis can be disastrous. For leaders in government, when millions ...

More than four years ago, President Donald Trump heralded the arrival of safe and effective messenger RNA (mRNA) vaccines for COVID-19. He called them “a monumental national achievement” and “one of ...

"I am saddened and outraged that more citizens are not tuning into this war against scientific health research in the United ...

The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not ...

Senior author Elias Sayour, M.D., Ph.D., a UF Health pediatric oncologist, said the results reveal a potential new treatment path — an alternative to surgery, radiation, and chemotherapy — with broad ...

The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has ...

The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not without risk. When this type of “genetic surgery” is performed on DNA, for ...

Researchers warn that halting federal contracts for mRNA vaccine research could weaken pandemic preparedness and slow medical advances.

Dubbed the ‘guardian of the genome’, the p53 protein responds to DNA damage by stalling cell division, initiating DNA repair or triggering cell death. This well-known pathway is frequently mutated or ...

The cuts risk making the world a more dangerous place. To assess the impact of these measures, The Economist spoke to more ...

In 1957, just four years after Francis Crick and other scientists solved the riddle of DNA’s structure—the now famous double ...